BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21744505)

  • 1. Chemical modification and organelle-specific localization of orlistat-like natural-product-based probes.
    Yang PY; Liu K; Zhang C; Chen GY; Shen Y; Ngai MH; Lear MJ; Yao SQ
    Chem Asian J; 2011 Oct; 6(10):2762-75. PubMed ID: 21744505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities.
    Yang PY; Liu K; Ngai MH; Lear MJ; Wenk MR; Yao SQ
    J Am Chem Soc; 2010 Jan; 132(2):656-66. PubMed ID: 20028024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
    Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
    Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural product CCR5 antagonist anibamine and its analogs as anti-prostate cancer agents.
    Haney KM; Zhang F; Arnatt CK; Yuan Y; Li G; Ware JL; Gewirtz DA; Zhang Y
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5159-63. PubMed ID: 21820898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of anticancer natural product analogues based on angelmarin: targeting the tolerance towards nutrient deprivation.
    Magolan J; Adams NB; Onozuka H; Hungerford NL; Esumi H; Coster MJ
    ChemMedChem; 2012 May; 7(5):766-70. PubMed ID: 22431333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastereoselective one-pot Wittig olefination-Michael addition and olefin cross metathesis strategy for total synthesis of cytotoxic natural product (+)-varitriol and its higher analogues.
    Ghosal P; Sharma D; Kumar B; Meena S; Sinha S; Shaw AK
    Org Biomol Chem; 2011 Nov; 9(21):7372-83. PubMed ID: 21897926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat.
    Huang HQ; Tang J; Zhou ST; Yi T; Peng HL; Shen GB; Xie N; Huang K; Yang T; Wu JH; Huang CH; Wei YQ; Zhao X
    Int J Oncol; 2012 Aug; 41(2):523-32. PubMed ID: 22581080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
    Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
    Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-lactones alpha,beta- and beta,gamma-fused to carbocycles as novel antiproliferative drugs.
    León LG; Machín RP; Rodríguez CM; Ravelo JL; Martín VS; Padrón JM
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5171-3. PubMed ID: 18789684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
    Shultz M; Fan J; Chen C; Cho YS; Davis N; Bickford S; Buteau K; Cao X; Holmqvist M; Hsu M; Jiang L; Liu G; Lu Q; Patel C; Suresh JR; Selvaraj M; Urban L; Wang P; Yan-Neale Y; Whitehead L; Zhang H; Zhou L; Atadja P
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4909-12. PubMed ID: 21742496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Click-based synthesis and proteomic profiling of lipstatin analogues.
    Ngai MH; Yang PY; Liu K; Shen Y; Wenk MR; Yao SQ; Lear MJ
    Chem Commun (Camb); 2010 Nov; 46(44):8335-7. PubMed ID: 20577697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
    Griffiths M; Sundaram H
    Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumour activity of new muricatacin and goniofufurone analogues.
    Popsavin V; Srećo B; Krstić I; Popsavin M; Kojić V; Bogdanović G
    Eur J Med Chem; 2006 Oct; 41(10):1217-22. PubMed ID: 16891043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying small molecule microarrays and resulting affinity probe cocktails for proteome profiling of mammalian cell lysates.
    Shi H; Uttamchandani M; Yao SQ
    Chem Asian J; 2011 Oct; 6(10):2803-15. PubMed ID: 21898842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of simplified analogues of (+)-discodermolide. Additional insights on the importance of the diene, the C7 hydroxyl, and the lactone.
    Smith AB; Xian M
    Org Lett; 2005 Nov; 7(23):5229-32. PubMed ID: 16268545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of pironetin analogues with simplified structure and study of their interactions with microtubules.
    Marco JA; García-Pla J; Carda M; Murga J; Falomir E; Trigili C; Notararigo S; Díaz JF; Barasoain I
    Eur J Med Chem; 2011 May; 46(5):1630-7. PubMed ID: 21396747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs.
    Romero M; Renard P; Caignard DH; Atassi G; Solans X; Constans P; Bailly C; Pujol MD
    J Med Chem; 2007 Jan; 50(2):294-307. PubMed ID: 17228871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An array of bengamide E analogues modified at the terminal olefinic position: synthesis and antitumor properties.
    Martín-Gálvez F; García-Ruiz C; Sánchez-Ruiz A; Valeriote FA; Sarabia F
    ChemMedChem; 2013 May; 8(5):819-31. PubMed ID: 23512621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agents.
    Zhang F; Arnatt CK; Haney KM; Fang HC; Bajacan JE; Richardson AC; Ware JL; Zhang Y
    Eur J Med Chem; 2012 Sep; 55():395-408. PubMed ID: 22901310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and cytotoxic activities of novel hybrid compounds between dihydrobenzofuran and imidazole.
    Chen W; Yang XD; Li Y; Yang LJ; Wang XQ; Zhang GL; Zhang HB
    Org Biomol Chem; 2011 Jun; 9(11):4250-5. PubMed ID: 21505704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.